Why Valeant Pharmaceuticals Is Crashing 48% Today. Sluggish profit and a ratcheting down of its financial forecast for this year are weighing on the company's shares. Mar 15, 2016 at 1:23PM. CEO Michael Pearson has his work cut out for him.